Winning Health Technology Group Co., Ltd. (SHE:300253)
China · Delayed Price · Currency is CNY 8.52
-0.09 (-1.05%)
Apr 17, 2026, 3:08 PM CST
SHE:300253 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 2,106 | 2,782 | 3,161 | 3,091 | 2,749 |
Other Revenue | 0.01 | 0.44 | 2.47 | 1.38 | 0.94 |
| 2,106 | 2,782 | 3,163 | 3,093 | 2,750 | |
Revenue Growth (YoY) | -24.30% | -12.05% | 2.28% | 12.46% | 21.34% |
Cost of Revenue | 1,415 | 1,623 | 1,741 | 1,742 | 1,476 |
Gross Profit | 691.43 | 1,159 | 1,423 | 1,351 | 1,275 |
Selling, General & Admin | 497.8 | 545.37 | 653.83 | 707.67 | 585.95 |
Research & Development | 333.54 | 264.63 | 333.3 | 313.77 | 255.67 |
Other Operating Expenses | -50.99 | -107.76 | -99.28 | 25.8 | -79.54 |
Operating Expenses | 915.62 | 888.61 | 1,027 | 1,282 | 995.35 |
Operating Income | -224.19 | 270.25 | 395.28 | 69.54 | 279.34 |
Interest Expense | -68.6 | -66.76 | -64.05 | -59.63 | -46.68 |
Interest & Investment Income | 6.92 | 10.14 | 43.09 | 20.62 | 11.8 |
Currency Exchange Gain (Loss) | - | - | -0.01 | - | 0 |
Other Non Operating Income (Expenses) | -13.14 | -5.32 | 0.78 | -14.25 | -22.38 |
EBT Excluding Unusual Items | -299.01 | 208.31 | 375.09 | 16.28 | 222.08 |
Impairment of Goodwill | -87.69 | -63.64 | -6.6 | -22.94 | - |
Gain (Loss) on Sale of Investments | -66.37 | -76.83 | -50.46 | -90.56 | 116.51 |
Gain (Loss) on Sale of Assets | 3.05 | -0.28 | -0.43 | -0.52 | 0.18 |
Asset Writedown | -0.28 | -0.09 | -0.05 | -0.31 | -0.31 |
Legal Settlements | - | - | -0.26 | - | - |
Other Unusual Items | 7.83 | 19.49 | 23.46 | 136.6 | 34.72 |
Pretax Income | -442.48 | 86.96 | 340.75 | 38.54 | 373.17 |
Income Tax Expense | -58.3 | 36.89 | 23.13 | 23.78 | 19.43 |
Earnings From Continuing Operations | -384.17 | 50.07 | 317.62 | 14.76 | 353.73 |
Minority Interest in Earnings | 10.29 | 37.83 | 40.34 | 93.88 | 24.44 |
Net Income | -373.88 | 87.89 | 357.96 | 108.64 | 378.17 |
Net Income to Common | -373.88 | 87.89 | 357.96 | 108.64 | 378.17 |
Net Income Growth | - | -75.45% | 229.49% | -71.27% | -22.99% |
Shares Outstanding (Basic) | 2,210 | 2,154 | 2,147 | 2,139 | 2,143 |
Shares Outstanding (Diluted) | 2,210 | 2,160 | 2,195 | 2,143 | 2,147 |
Shares Change (YoY) | 2.32% | -1.60% | 2.42% | -0.22% | 0.44% |
EPS (Basic) | -0.17 | 0.04 | 0.17 | 0.05 | 0.18 |
EPS (Diluted) | -0.17 | 0.04 | 0.16 | 0.05 | 0.18 |
EPS Growth | - | -75.05% | 221.70% | -71.21% | -23.34% |
Free Cash Flow | 335.01 | 101.71 | -128.53 | -223.26 | 81.83 |
Free Cash Flow Per Share | 0.15 | 0.05 | -0.06 | -0.10 | 0.04 |
Dividend Per Share | - | 0.015 | 0.020 | 0.010 | 0.020 |
Dividend Growth | - | -25.00% | 100.00% | -50.00% | -20.00% |
Gross Margin | 32.83% | 41.65% | 44.97% | 43.69% | 46.35% |
Operating Margin | -10.64% | 9.71% | 12.50% | 2.25% | 10.16% |
Profit Margin | -17.75% | 3.16% | 11.32% | 3.51% | 13.75% |
Free Cash Flow Margin | 15.91% | 3.66% | -4.06% | -7.22% | 2.97% |
EBITDA | -204.03 | 293.17 | 417.06 | 90.9 | 299.2 |
EBITDA Margin | -9.69% | 10.54% | 13.18% | 2.94% | 10.88% |
D&A For EBITDA | 20.16 | 22.91 | 21.77 | 21.35 | 19.86 |
EBIT | -224.19 | 270.25 | 395.28 | 69.54 | 279.34 |
EBIT Margin | -10.64% | 9.71% | 12.50% | 2.25% | 10.16% |
Effective Tax Rate | - | 42.42% | 6.79% | 61.71% | 5.21% |
Revenue as Reported | 2,106 | 2,782 | 3,163 | 3,093 | 2,750 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.